This study found that patients who showed biliary MIC-1 levels higher than the cut-off value were significantly more likely to belong to the Stage I/II biliary cancer group than the benign group, which demonstrates that biliary MIC-1 might be useful for diagnosing biliary tract cancer in the early stages. This evidence concerns the gene GDF15 and biliary tract cancer.